Studies Investigating Co-morbidities Aggravating Heart Failure

Summary

SICA-HF is a prospective, multicentre, multinational, longitudinal, pathophysiological evaluation study, which is being conducted in 11 centres across six countries. SICA-HF receives funding from the European commission's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 241558 (SICA-HF) and from the Russian Ministry of Science and Education within the file transfer protocol "R\&D in priority fields of the S\&T complex of Russia 2007-2012" under state contract number 02.527.11.0007. The aim of SICA-HF is to provide detailed characteristics of co-morbidities of heart failure at baseline and over time, particularly with regards to obesity, cachexia, and type 2 diabetes.

Conditions

• Heart Failure
• Type 2 Diabetes Mellitus

Sponsors & Collaborators

• University of Hull

  collaborator OTHER

• Wroclaw Medical University

  collaborator OTHER

• IRCCS San Raffaele

  collaborator OTHER

• Hannover Medical School

  collaborator OTHER

• Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

  collaborator OTHER

• Moscow State University of Medicine and Dentistry

  collaborator OTHER

• Siberian Branch of the Russian Academy of Medical Sciences

  collaborator OTHER

• Russian Cardiology Research and Production Center

  collaborator OTHER

• The University Clinic of Pulmonary and Allergic Diseases Golnik

  collaborator OTHER

• Silesian Centre for Heart Diseases

  collaborator OTHER

• Charite University, Berlin, Germany

  lead OTHER

Principal Investigators

• Stefan D Anker, MD, PhD · Charité- University Medicine Berlin, Campus Virchow Klinikum

• Stephan von Haehling, MD, PhD · Charité- University Medicine Berlin, Campus Virchow Klinikum

• John Cleland, MD, PhD · University of Hull

• Piotr Ponikowski, MD, PhD · Wroclaw Medical University

• Giuseppe Rosano, MD, PhD · IRCCS San Raffaele

• Jens Jordan, MD, PhD · Hannover Medical School

• Eugeniy Shlyakhto, MD, PhD · Almazov Federal Center for Heart, Blood & Endocrinology

• Vsevolod Tkachuk, MD, PhD · Lomonosov Moscow State University

• Rostislav Karpov, MD, PhD · Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences

• Yelena Parfyonova, MD, PhD · Russian Cardiology Research and Production Complex

• Mitja Lainscak, MD, PhD · University Clinic of Respiratory and Allergic diseases Golnik

• Piotr Rozentryt, MD, PhD · Silesian Centre for Heart Diseases

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2010-03-31

Primary Completion

2015-04-30

Completion

2016-07-31

Countries

• Germany
• Italy
• Poland
• Russia
• Slovenia
• United Kingdom

Study Locations